This is a summary of: Liu. H. et al. Viral RNA blocks circularization to evade host codon usage control. Nature https://doi.org/10.1038/s41586-025-09809-y (2025).
Especially on X, algorithmic culture is characterized by ceaseless iteration: Everything that’s happening is piled atop all ...
Abstract: Path coverage is of critical importance in software testing and verification. Furthermore, path explosion is a well-known challenge for automatic software analysis techniques like symbolic ...
The last major Windows 11 23H2 feature update was released in Fall 2023. Contrary to previous fears, Windows 10 users are not completely excluded from further development. Microsoft is also planning ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...
Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...
Microsoft has introduced a new device category with Copilot+. Only laptops with a dedicated Neural Processing Unit (NPU), at least 16 GB of RAM and a fast NVMe SSD fulfil the minimum requirements.
Recursion Pharmaceuticals (NASDAQ: RXRX) is not the most famous artificial intelligence (AI) stock on the market, but the biotech (or techbio) company has attracted the attention of some big names.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback